320 related articles for article (PubMed ID: 27242236)
21. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
Sampaio EP; Kaplan G; Miranda A; Nery JA; Miguel CP; Viana SM; Sarno EN
J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
Job CK; Jacobson RR; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for erythema nodosum leprosum.
Manandhar R; LeMaster JW; Roche PW
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
[TBL] [Abstract][Full Text] [Related]
24. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
[TBL] [Abstract][Full Text] [Related]
25. The role of etanercept in refractory erythema nodosum leprosum.
Thangaraju P; Durai V; Showkath Ali MK
Int J Mycobacteriol; 2016 Sep; 5(3):368-369. PubMed ID: 27847029
[No Abstract] [Full Text] [Related]
26. Recognizing and managing the immunologic reactions in leprosy.
Kamath S; Vaccaro SA; Rea TH; Ochoa MT
J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
[TBL] [Abstract][Full Text] [Related]
27. Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.
Gupta SK; Kumari S
An Bras Dermatol; 2022; 97(1):49-53. PubMed ID: 34848113
[TBL] [Abstract][Full Text] [Related]
28. [Effectiveness of thalidomide for erythema nodosum leprosum (ENL): retrospective study of 20 Japanese cases in National Sanatrium Oku-Komyoen].
Matsuki T; Okano Y; Aoki Y; Ishida Y; Hatano K; Kumano K
Nihon Hansenbyo Gakkai Zasshi; 2014 Dec; 83(3):1-6. PubMed ID: 25826849
[TBL] [Abstract][Full Text] [Related]
29. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
30. Suppressed natural killer cell activity during episodes of erythema nodosum leprosum in lepromatous leprosy.
Humphres RC; Gelber RH; Krahenbuhl JL
Clin Exp Immunol; 1982 Sep; 49(3):500-8. PubMed ID: 7172493
[TBL] [Abstract][Full Text] [Related]
31. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
32. Effect of cyclosporine A in erythema nodosum leprosum.
Uyemura K; Dixon JF; Wong L; Rea TH; Modlin RL
J Immunol; 1986 Dec; 137(11):3620-3. PubMed ID: 2946765
[TBL] [Abstract][Full Text] [Related]
33. Increased serum levels of interleukin-6 in erythema nodosum leprosum suggest its use as a biomarker.
Vilani-Moreno FR; Brito-de-Souza VN; Silva SMUR; Barbosa ASAA; Sartori BGC; Campanelli AP; Barreto JA; Virmond MDCL
Indian J Dermatol Venereol Leprol; 2021; 87(2):190-198. PubMed ID: 33769734
[TBL] [Abstract][Full Text] [Related]
34. Reverse Koebner phenomenon in erythema nodosum leprosum.
Singh S; Narang T; Dogra S
Trans R Soc Trop Med Hyg; 2024 Jan; 118(1):77-79. PubMed ID: 37632458
[TBL] [Abstract][Full Text] [Related]
35. [Review: update on erythema nodosum leprosum].
Morand JJ; Badiane C; Bobin P
Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
[TBL] [Abstract][Full Text] [Related]
36. Erythema nodosum leprosum.
Kwittken J
Int J Lepr Other Mycobact Dis; 1968; 36(1):94-5. PubMed ID: 5689653
[No Abstract] [Full Text] [Related]
37. Group specific component (Gc) in erythema nodosum leprosum (ENL).
Ghei SK; Agrewala JN; Sengupta U; Sudhakar KS
Indian J Lepr; 1993; 65(3):323-5. PubMed ID: 8283068
[TBL] [Abstract][Full Text] [Related]
38. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
Gupta N; Shankernarayan NP; Dharmalingam K
J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
[TBL] [Abstract][Full Text] [Related]
39. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
40. Biologics in Leprosy: A Systematic Review and Case Report.
Cogen AL; Lebas E; De Barros B; Harnisch JP; Faber WR; Lockwood DN; Walker SL
Am J Trop Med Hyg; 2020 May; 102(5):1131-1136. PubMed ID: 32157993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
